Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
10/23/1991 | EP0453119A1 Modified beta adrenergic receptor |
10/23/1991 | EP0452925A2 Isolated DNA coding for spider silk protein, a replicable vector and a transformed cell containing the isolated DNA, and products thereof |
10/23/1991 | EP0452849A1 Anti-PP4 monoclonal antibodies, method for production and use thereof |
10/23/1991 | EP0452508A1 Mouse antibody v-region gene fragment and preparation of chimera antibody by using said gene fragment |
10/23/1991 | EP0452433A1 Cytolysis inhibitor proteins (cli) and dna sequences coding for said proteins |
10/23/1991 | EP0452413A1 Generation and selection of novel dna-binding proteins and polypeptides |
10/23/1991 | EP0452391A1 A polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide. |
10/23/1991 | EP0452364A1 Method for preparing water soluble polypeptides |
10/23/1991 | EP0452319A1 Novel protein and coding sequence for detection and differentiation of siv and hiv-2 group of viruses |
10/23/1991 | EP0452315A1 Method of treating myeloid leukemias |
10/23/1991 | EP0418230A4 Method for potentiating and inhibiting insulin-like growth factor activity |
10/22/1991 | WO1991016447A1 A co-hydrolytic process for the production of novel extracts from yeast and non-yeast proteins |
10/22/1991 | US5059680 Method of isolating ca 125 antigen |
10/22/1991 | US5059538 Recombinant plasmid inserted with herpes simplex virus gene |
10/22/1991 | US5059537 Acellular vaccine |
10/22/1991 | US5059528 Expression of human proapolipoprotein a-i |
10/22/1991 | US5059521 Diagnostic reagent; cancer detection; leukemia; labeling |
10/22/1991 | CA2080923A1 Co-hydrolytic process for the production of novel extracts from yeast and non-yeast proteins |
10/22/1991 | CA1291292C Purification of recombinant tumor necrosis factor |
10/21/1991 | WO1991016448A1 Human monoclonal antibody against glycoprotein gp iii of varicella zoster virus |
10/19/1991 | WO1991017187A2 A 35kD TUMOR ASSOCIATED PROTEIN ANTIGEN: USES AND METHODS OF DETECTION |
10/19/1991 | CA2080835A1 A 35kd tumor associated protein antigen and immune complex |
10/19/1991 | CA2040722A1 Monoclonal antibodies against pp4, processes for the preparation thereof and the use thereof |
10/18/1991 | CA2040566A1 Biosynthesis of proteins in transgenic drosophila |
10/17/1991 | WO1991016348A1 Interleukin-4 binding protein-gamma |
10/17/1991 | WO1991015771A1 Combinations of hepatitis c virus (hcv) antigens for use in immunoassays for anti-hcv antibodies |
10/17/1991 | WO1991015603A1 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
10/17/1991 | WO1991015589A1 Improved process of purifying recombinant proteins and compounds useful in such process |
10/17/1991 | WO1991015587A1 Self-polymerising expression system based on modified potyvirus coat proteins |
10/17/1991 | WO1991015586A1 Improvements relating to the detection of viruses |
10/17/1991 | WO1991015582A2 PURIFIED RAP GAPs, RAP GAP SEQUENCES, AND USES THEREOF |
10/17/1991 | WO1991015581A1 Walk-through mutagenesis |
10/17/1991 | WO1991015580A1 Gene therapy for cell proliferative diseases |
10/17/1991 | WO1991015571A1 Expression of heterologous protein in yeast |
10/17/1991 | WO1991015514A1 Oxidation resistant thrombomodulin analogs |
10/17/1991 | WO1991015513A1 Polypeptides with a dopaminergic receptor activity, nucleic acids coding for these polypeptides and use of these polypeptides to screen active substances on these polypeptides |
10/17/1991 | WO1991015238A1 Methods and compositions for vaccination against hiv |
10/17/1991 | WO1991015237A1 Compositions and treatments for pneumonia in animals |
10/17/1991 | WO1991015227A1 Method and compositions for treating injury |
10/17/1991 | WO1991008298A3 Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
10/17/1991 | WO1991006658A3 Infective protein delivery system |
10/17/1991 | WO1991000916A3 Receptors for fibroblast growth factors |
10/17/1991 | CA2079903A1 Gene therapy for cell proliferative diseases |
10/17/1991 | CA2079600A1 Interleukin-4 binding protein-gamma |
10/17/1991 | CA2078546A1 Methods and compositions for vaccination against hiv |
10/17/1991 | CA2040513A1 Method of diagnosing cancer |
10/16/1991 | EP0451957A2 Cyclohexapeptide compound |
10/16/1991 | EP0451878A1 Modifying plants by genetic engineering to combat or control insects |
10/16/1991 | EP0451700A1 Recombinant APP minigenes for expression in transgenic mice as models for Alzheimers's disease |
10/16/1991 | EP0451612A1 Anti-oncostatin M monoclonal antibodies |
10/16/1991 | EP0451550A2 Seroreactive epitopes of human Papillomavirus (HPV) 16 proteins |
10/16/1991 | EP0451547A1 1,4,8-Triazacyclotridecane derivatives having prolyl endopeptidase inhibiting activity |
10/16/1991 | EP0451486A1 Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2,E and T |
10/16/1991 | EP0451357A1 Pathogenesis factors of dermatophytes |
10/16/1991 | EP0451244A1 Subtilisin mutants |
10/16/1991 | EP0451211A1 Cloning and production of polypeptide analogs of human fibronectin and method of using such polypeptide analogs |
10/16/1991 | EP0451206A1 Receptor transcription-repression activity compositions and methods |
10/16/1991 | EP0434744A4 Serum immunoregulatory polypeptide and uses therefor |
10/16/1991 | EP0423193A4 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human |
10/16/1991 | EP0193561B1 Monoclonal antibodies against metal chelates |
10/16/1991 | CN1055389A Novel proteins with oncostatin m activity and process for their preparation |
10/15/1991 | US5057493 Cyclic peptides, also fungicides |
10/15/1991 | US5057422 Recombinant dna: transformed microorganisms, plant cells and plants: a process for introducing an inducible property in plants, and a process for producing a polypeptide or protein by means of plants or plant cells |
10/15/1991 | US5057417 Compositions and methods for the synthesis of growth hormone receptor and growth hormone binding protein |
10/15/1991 | US5057416 For polypeptide products |
10/15/1991 | US5057415 Continuous enzymatic process for preparing peptides |
10/15/1991 | US5057411 For identifying specific viruses |
10/15/1991 | CA1290713C Protein and production thereof |
10/15/1991 | CA1290712C Multidrug resistance in mammalian cell lines and isolation of determinant glycoprotein dna |
10/10/1991 | WO1992017583A1 Isolated viral protein cytokine antagonists |
10/10/1991 | WO1991015503A1 T-cell suppressor protein |
10/10/1991 | CA2080371A1 T-cell suppressor protein |
10/09/1991 | EP0450936A1 Monoclonal antibody to avermectins |
10/09/1991 | EP0450931A1 Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies |
10/09/1991 | EP0450813A2 Protein phosphatase inhibitor-1 gene and expression |
10/09/1991 | EP0450573A2 Antibodies for the treatment and diagnosis of Pseudomonas aeruginosa infections |
10/09/1991 | EP0450479A1 Bispecific monoclonal anti-bodies, their production and use |
10/09/1991 | EP0450472A1 Monoclonal antibodies that inhibit growth of kaposi's sarcoma |
10/09/1991 | EP0450430A2 DNA sequence comprising a structural gene coding for xylose reductase or xylose reductase and xylitol dehydrogenase |
10/09/1991 | EP0450240A1 Anti-aids preparation |
10/09/1991 | EP0449956A1 Novel lymphokine/cytokine genes |
10/09/1991 | EP0449879A1 Heterobifunctional antibodies having specificity for platelets and thrombolytic agents |
10/09/1991 | EP0449856A1 Pneumolysin mutants and pneumococcal vaccines made therefrom |
10/09/1991 | EP0449839A1 Improved bacterial strains for heterologous gene expression |
10/09/1991 | EP0449828A1 HUMAN Fc$g(g) RECEPTOR III |
10/09/1991 | CN1055200A Method to build clones with lead-changing penicillium and streptomycete of human tumor necrotic factor (tnf) alpha |
10/08/1991 | US5055560 Useful in detection of leucine 22 antigen on T-cells fixed in formalin, zinc sulfate or Bouin's fixative |
10/08/1991 | US5055558 Method for the selective deproteinization of whey |
10/08/1991 | US5055455 Inhibiting adhesion of coagulase-negative staphylococcus to a polymeric material |
10/08/1991 | US5055405 Hybridoma cell line and monoclonal antibodies to Treponema species T. denticola JD-1 and Treponema 10A |
10/08/1991 | US5055404 Monoclonal antibody specifically reactive to surface of human prostatic epithelial cells |
10/08/1991 | US5055399 Enzymatic synthesis of alpha-L-aspartyl-L-phenyalanine lower alkyl esters |
10/08/1991 | US5055396 Diagnostic methods and systems for quantifying apo ai |
10/08/1991 | US5055289 Dual specificity against therapeutically active agent and against a disease related antigen |
10/08/1991 | CA1290267C Human anti-inflammatory phospholipase inhibitor protein |
10/08/1991 | CA1290266C Monoclonal antibodies to unreduced nonenzymatically glycated proteins |
10/08/1991 | CA1290265C Monoclonal antibody specific for a pigmentation associated antigen |
10/08/1991 | CA1290245C Methods for diagnosis and therapy of multiple sclerosis |
10/07/1991 | WO1991015516A2 Hepatitis c virus epitopes |
10/07/1991 | WO1991015230A1 Ligand for the neu gene product |